Organ distribution of 4-MEC, MDPV, methoxetamine and α-PVP: comparison of QuEChERS and SPE

United Nations Office on Drugs and Crime (UNODC) (2016) New psychoactive substances: overview of trends, challenges and legal approaches. vol E/CN.7/2016/CRP.2 Guirguis A, Corkery JM, Stair JL, Kirton SB, Zloh M, Schifano F (2017) Intended and unintended use of cathinone mixtures. Hum Psychopharmacol Clin Exp 32:1–17 US Drug Enforcement Administration (2014) Schedules of controlled substances: temporary placement of 10 synthetic cathinones into schedule I. Fed Regist 79:12938–12943 Ross EA, Watson M, Goldberger B (2011) “Bath salts” intoxication. N Engl J Med 365:967–968 Spiller HA, Ryan ML, Weston RG, Jansen J (2011) Clinical experience with and analytical confirmation of “bath salts” and “legal highs”(synthetic cathinones) in the United States. Clin Toxicol 49:499–505 Giannotti G, Canazza I, Caffino L, Bilel S, Ossato A, Fumagalli F, Marti M (2017) The cathinones MDPV and α-PVP elicit different behavioral and molecular effects following acute exposure. Neurotox Res 32:594–602 Marusich JA, Antonazzo KR, Wiley JL, Blough BE, Partilla JS, Baumann MH (2014) Pharmacology of novel synthetic stimulants structurally related to the “bath salts” constituent 3, 4-methylenedioxypyrovalerone (MDPV). Neuropharmacology 87:206–213 US Drug Enforcement Administration (2011) Schedules of controlled substances: temporary placement of three synthetic cathinones in Schedule I. Fed Regist 76:65371–65375 World Health Organization (2014) 4-Methylethcathinone (4-MEC): critical review report. Expert Committee on Drug Dependence 36th ECDD Agenda item 4.3 Winstock AR, Mitcheson LR, Deluca P, Davey Z, Corazza O, Schifano F (2011) Mephedrone, new kid for the chop? Addiction 106:154–161 Gil D, Adamowicz P, Skulska A, Tokarczyk B, Stanaszek R (2013) Analysis of 4-MEC in biological and non-biological material—three case reports. Forensic Sci Int 228:e11–e15 Corazza O, Schifano F, Simonato P, Fergus S, Assi S, Stair J, Corkery J, Trincas G, Deluca P, Davey Z (2012) Phenomenon of new drugs on the Internet: the case of ketamine derivative methoxetamine. Hum Psychopharmacol Clin Exp 27:145–149 Kumlien E, Hartvig P, Valind S, Øye I, Tedroff J, Långström B (1999) NMDA-receptor activity visualized with (S)-[N-methyl-11C] ketamine and positron emission tomography in patients with medial temporal lobe epilepsy. Epilepsia 40:30–37 Lehmann S, Kieliba T, Beike J, Thevis M, Mercer-Chalmers-Bender K (2017) Determination of 74 new psychoactive substances in serum using automated in-line solid-phase extraction-liquid chromatography–tandem mass spectrometry. J Chromatogr B 1064:124–138 Hasegawa K, Wurita A, Minakata K, Gonmori K, Nozawa H, Yamagishi I, Watanabe K, Suzuki O (2015) Postmortem distribution of AB-CHMINACA, 5-fluoro-AMB, and diphenidine in body fluids and solid tissues in a fatal poisoning case: usefulness of adipose tissue for detection of the drugs in unchanged forms. Forensic Toxicol 33:45–53 Anastassiades M, Lehotay SJ, Štajnbaher D, Schenck FJ (2003) Fast and easy multiresidue method employing acetonitrile extraction/partitioning and “dispersive solid-phase extraction” for the determination of pesticide residues in produce. J AOAC Int 86:412–431 Kudo K, Usumoto Y, Kikura-Hanajiri R, Sameshima N, Tsuji A, Ikeda N (2015) A fatal case of poisoning related to new cathinone designer drugs, 4-methoxy PV8, PV9, and 4-methoxy PV9, and a dissociative agent, diphenidine. Leg Med 17:421–426 Usui K, Aramaki T, Hashiyada M, Hayashizaki Y, Funayama M (2014) Quantitative analysis of 3, 4-dimethylmethcathinone in blood and urine by liquid chromatography–tandem mass spectrometry in a fatal case. Leg Med 16:222–226 Usui K, Hayashizaki Y, Hashiyada M, Funayama M (2012) Rapid drug extraction from human whole blood using a modified QuEChERS extraction method. Leg Med 14:286–296 Gaunitz F, Schürenkamp J, Rostamzadeh A, Konkol C, Thevis M, Rothschild MA, Mercer-Chalmers-Bender K (2017) Analysis of taxine B/isotaxine B in a plasma specimen by LC–MS/MS in a case of fatal poisoning: concealed suicide by ingestion of yew (Taxus L.) leaves of a patient with a long-term history of borderline personality disorder. Forensic Toxicol 35:421–427 Pragst F, Herzler M, Erxleben B-T (2004) Systematic toxicological analysis by high-performance liquid chromatography with diode array detection (HPLC–DAD). Clin Chem Lab Med 42:1325–1340 Schulz M, Iwersen-Bergmann S, Andresen H, Schmoldt A (2012) Therapeutic and toxic blood concentrations of nearly 1000 drugs and other xenobiotics. Crit Care 16:R136. https://doi.org/10.1186/cc11441 Thomas A, Schänzer W, Thevis M (2014) Determination of human insulin and its analogues in human blood using liquid chromatography coupled to ion mobility mass spectrometry (LC–IM-MS). Drug Test Anal 6:1125–1132 Cuadros-Rodríguez L, Bagur-González MG, Sánchez-Vinas M, González-Casado A, Gómez-Sáez AM (2007) Principles of analytical calibration/quantification for the separation sciences. J Chromatogr A 1158:33–46 Paul L, Musshoff F, Aebi B, Auwärter V, Krämer T, Peters F, Skopp G, Aderjan R, Herbold M, Schmitt G (2009) Richtlinie der GTFCh zur Qualitätssicherung bei forensisch-toxikologischen Untersuchungen. Toxichem Krimtech 76:142–176 Peters FT, Drummer OH, Musshoff F (2007) Validation of new methods. Forensic Sci Int 165:216–224 Matuszewski B, Constanzer M, Chavez-Eng C (2003) Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC–MS/MS. Anal Chem 75:3019–3030 Peters F, Musshoff F, Kraemer T (2009) Anhang B. Richtlinie der GTFCh zur Qualitätssicherung bei forensisch-toxikologischen Untersuchungen Anforderungen an die Validierung von Analysenmethoden. Toxichem Krimtech 76:185–208 European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) (2014) Europol Joint Report on a new psychoactive substance: MDPV (3,4-methylenedioxypyrovalerone). Publications Office of the European Union, Luxembourg. https://doi.org/10.2810/24085 Katselou M, Papoutsis I, Nikolaou P, Spiliopoulou C, Athanaselis S (2016) α-PVP (“flakka”): a new synthetic cathinone invades the drug arena. Forensic Toxicol 34:41–50 Araújo AM, Valente MJ, Carvalho M, Da Silva DD, Gaspar H, Carvalho F, de Lourdes Bastos M, De Pinho PG (2015) Raising awareness of new psychoactive substances: chemical analysis and in vitro toxicity screening of ‘legal high’ packages containing synthetic cathinones. Arch Toxicol 89:757–771 Leffler AM, Smith PB, de Armas A, Dorman FL (2014) The analytical investigation of synthetic street drugs containing cathinone analogs. Forensic Sci Int 234:50–56 Wyman JF, Lavins ES, Engelhart D, Armstrong EJ, Snell KD, Boggs PD, Taylor SM, Norris RN, Miller FP (2013) Postmortem tissue distribution of MDPV following lethal intoxication by “bath salts”. J Anal Toxicol 37:182–185 Cawrse BM, Levine B, Jufer RA, Fowler DR, Vorce SP, Dickson AJ, Holler JM (2012) Distribution of methylone in four postmortem cases. J Anal Toxicol 36:434–439 Wright TH, Cline-Parhamovich K, Lajoie D, Parsons L, Dunn M, Ferslew KE (2013) Deaths involving methylenedioxypyrovalerone (MDPV) in upper east Tennessee. J Forensic Sci 58:1558–1562 Murray BL, Murphy CM, Beuhler MC (2012) Death following recreational use of designer drug “bath salts” containing 3, 4-methylenedioxypyrovalerone (MDPV). J Med Toxicol 8:69–75 Hasegawa K, Suzuki O, Wurita A, Minakata K, Yamagishi I, Nozawa H, Gonmori K, Watanabe K (2014) Postmortem distribution of α-pyrrolidinovalerophenone and its metabolite in body fluids and solid tissues in a fatal poisoning case measured by LC–MS–MS with the standard addition method. Forensic Toxicol 32:225–234 Potocka-Banaś B, Janus T, Majdanik S, Banaś T, Dembińska T, Borowiak K (2017) Fatal intoxication with α-PVP, a synthetic cathinone derivative. J Forensic Sci 62:553–556 Saito T, Namera A, Osawa M, Aoki H, Inokuchi S (2013) SPME–GC–MS analysis of α-pyrrolidinovaleorophenone in blood in a fatal poisoning case. Forensic Toxicol 31:328–332 Knoy JL, Peterson BL, Couper FJ (2014) Suspected impaired driving case involving α-pyrrolidinovalerophenone, methylone and ethylone. J Anal Toxicol 38:615–617 Soh YNA, Elliott S (2014) An investigation of the stability of emerging new psychoactive substances. Drug Test Anal 6:696–704 Skopp G (2004) Preanalytic aspects in postmortem toxicology. Forensic Sci Int 142:75–100 Smith P, Cole R, Hamilton S, West K, Morley S, Maskell P (2016) Reporting two fatalities associated with the use of 4-methylethcathinone (4-MEC) and a review of the literature. J Anal Toxicol 40:553–560 Hajkova K, Jurasek B, Sykora D, Palenicek T, Miksatkova P, Kuchar M (2016) Salting-out-assisted liquid–liquid extraction as a suitable approach for determination of methoxetamine in large sets of tissue samples. Anal Bioanal Chem 408:1171–1181 Imbert L, Boucher A, Delhome G, Cueto T, Boudinaud M, Maublanc J, Dulaurent S, Descotes J, Lachâtre G, Gaulier J-M (2014) Analytical findings of an acute intoxication after inhalation of methoxetamine. J Anal Toxicol 38:410–415 Shields JE, Dargan PI, Wood DM, Puchnarewicz M, Davies S, Waring WS (2012) Methoxetamine associated reversible cerebellar toxicity: three cases with analytical confirmation. Clin Toxicol 50:438–440 Wood DM, Davies S, Puchnarewicz M, Johnston A, Dargan PI (2012) Acute toxicity associated with the recreational use of the ketamine derivative methoxetamine. Eur J Clin Pharmacol 68:853–856 Adamowicz P, Zuba D (2015) Fatal intoxication with methoxetamine. J Forensic Sci 60:S264–S268 Wikström M, Thelander G, Dahlgren M, Kronstrand R (2013) An accidental fatal intoxication with methoxetamine. J Anal Toxicol 37:43–46 Chiappini S, Claridge H, Corkery JM, Goodair C, Loi B, Schifano F (2015) Methoxetamine-related deaths in the UK: an overview. Hum Psychopharmacol Clin Exp 30:244–248 Wunder C, Kauert GF, Toennes SW (2014) Factors leading to the degradation/loss of insulin in postmortem blood samples. Forensic Sci Int 241:173–177